Immunogenicity of Anti-TNF-α Biotherapies: II. Clinical Relevance of Methods Used for Anti-Drug Antibody Detection

Immunogenicity of biopharmaceuticals is complex and influenced by both structural and pharmacological factors, and by patient-related conditions such as disease being treated, previous and concomitant therapies, and individual immune responsiveness. Essential for tailored therapeutic strategies base...

Descripción completa

Detalles Bibliográficos
Autor principal: Bendtzen, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389574/
https://www.ncbi.nlm.nih.gov/pubmed/25904911
http://dx.doi.org/10.3389/fimmu.2015.00109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389574/
https://www.ncbi.nlm.nih.gov/pubmed/25904911
http://dx.doi.org/10.3389/fimmu.2015.00109

Ejemplares similares